Staphylococcus epidermidis: Biofilm, Device Infections, and Lab Diagnosis

Eight months after a successful knee replacement, a patient returns with a knee that aches, feels stiff, and is mildly swollen. There is no high fever, no dramatic redness, none of the clinical signs you would expect from Staphylococcus aureus. The joint is just quietly not right. Fluid aspirated from the joint grows a coagulase-negative Staphylococcus: Staphylococcus epidermidis.

The puzzle is this: S. epidermidis is a weak pathogen that lives harmlessly on everyone's skin, so why has it settled on this prosthesis, and why is it so hard to cure that the surgeon is now discussing removing the implant? The answer is not a powerful toxin or an aggressive enzyme. It is biofilm, and it is the whole story of this organism as a pathogen.

Staphylococcus epidermidis is the most abundant bacterium on human skin and, for most of our lives, a harmless resident. Yet it is also the leading cause of infections on prosthetic joints, heart valves, and intravenous catheters. This article works through how a low-virulence skin commensal becomes so difficult to remove once it reaches a medical device, and how the laboratory identifies it.

What is Staphylococcus epidermidis?

Staphylococcus epidermidis is a Gram-positive coccus and one of the coagulase-negative staphylococci (CoNS). It is the dominant Staphylococcus of normal human skin and mucous membranes, where it is a beneficial commensal for most of life: it helps exclude more dangerous organisms, produces antimicrobial peptides, and helps train the developing immune system. For the wider picture of skin commensals and what they mean on a culture report, see normal flora of the skin.

The clinical importance of S. epidermidis comes almost entirely from a single shift in setting. On intact skin it is harmless. On the surface of an implanted medical device, the same organism becomes a persistent pathogen, because a device gives it a surface to build a biofilm on and bypasses the skin barrier that normally keeps it outside the body.

General characteristics

• Gram stain: Gram-positive cocci in clusters
• Catalase: positive (like all staphylococci)
• Coagulase: negative (this places it among the CoNS and separates it from S. aureus)
• Novobiocin: sensitive (this separates it from S. saprophyticus, which is resistant)
• Hemolysis: usually non-hemolytic on blood agar
• Urease: variable
• Colonies: small to medium, white, non-pigmented, usually non-hemolytic (unlike the golden, often beta-hemolytic colonies of S. aureus)
• Habitat: normal flora of skin and mucous membranes; facultative anaerobe

Diseases caused by Staphylococcus epidermidis

Almost all S. epidermidis disease is device-associated, and all of it follows one logic: the organism reaches an artificial surface, builds a biofilm on it, and becomes protected there from both antibiotics and the immune system. Reading the diseases this way, rather than as a list to memorize, explains why they behave the way they do: indolent, low-grade, and prone to relapse until the device is removed.

Prosthetic joint infection. S. epidermidis is a leading cause of infection on prosthetic hips and knees, often presenting late and quietly, months after surgery, with pain and loosening rather than acute sepsis. The biofilm on the implant is why the infection smolders and why antibiotics alone frequently fail.

Prosthetic valve endocarditis. On an artificial heart valve, S. epidermidis is a major cause of endocarditis, particularly within the first year after valve surgery. Native (natural) valves are far less often affected, which itself tells you the device, not the organism's inherent aggressiveness, is the key factor.

Catheter-related bloodstream infection. Intravenous catheters, especially central lines, are among the commonest routes for S. epidermidis to enter the blood. The organism colonizes the catheter surface and sheds into the bloodstream. Because S. epidermidis is also the commonest blood-culture contaminant, deciding whether a positive blood culture is a true line infection or skin contamination from the blood draw is a genuine clinical judgment, one made from the number of positive cultures, the clinical picture, and whether a device is present. That judgment is worked through in detail in normal flora of the skin.

CSF shunt infection. Cerebrospinal fluid shunts placed for hydrocephalus are frequently infected by S. epidermidis introduced at surgery, presenting with shunt malfunction or low-grade inflammation rather than florid meningitis.

Other device infections. S. epidermidis also infects peritoneal dialysis catheters (a common cause of CAPD peritonitis), vascular grafts, pacemaker leads, and prosthetic material in general. In neonatal intensive care, it is a frequent cause of device-associated late-onset sepsis in premature infants, whose skin barrier and immune defenses are immature.

The through-line: wherever there is implanted foreign material, S. epidermidis is a candidate, and the reason is always the same, biofilm on the surface.

Why this organism causes disease where it does

S. epidermidis has few of the aggressive toxins and enzymes that make S. aureus dangerous. Its pathogenicity rests almost entirely on one capability: attaching to artificial surfaces and building a biofilm.

Attachment to the device. The organism first binds to the implant, either directly to the material or to the host proteins (such as fibrinogen and fibronectin) that coat any device within minutes of implantation. Surface adhesins mediate this first grip.

Building the biofilm. Once attached, S. epidermidis produces a sticky extracellular matrix and accumulates into multilayered communities. The key molecule in many strains is polysaccharide intercellular adhesin (PIA), which glues the cells to one another and to the surface. PIA is synthesized by enzymes encoded by the ica operon (intercellular adhesin genes). Strains carrying a functional ica operon are strongly associated with device infection, which is one of the clearest examples in staphylococci of a single genetic locus mapping onto clinical behavior. For how biofilms form and mature as a general process, see biofilm formation.

Why the biofilm makes the infection so hard to cure. The biofilm is not just a physical shell. It protects the bacteria inside in three ways at once. It slows antibiotic penetration; it shelters slow-growing, metabolically dormant cells that most antibiotics (which target active growth) cannot kill; and it hides the organism from neutrophils and antibody. This is why S. epidermidis device infections are tolerant to antibiotics even when the isolate tests susceptible in the lab, and it is the central clinical consequence of this whole section: the infection often cannot be cured while the device remains, so definitive treatment usually requires removing or replacing the infected hardware. This antibiotic tolerance is a property of the biofilm state, not the same thing as the genetic drug resistance discussed below.

Laboratory diagnosis

• Gram staining: Gram-positive cocci in clusters. For the method, see Gram staining.
• Culture: small, white, usually non-hemolytic colonies on blood agar.
• Catalase: positive, separating it from streptococci.
• Coagulase: negative, placing it among the CoNS and separating it from S. aureus.
• Novobiocin: sensitive. In a coagulase-negative Staphylococcus from urine, novobiocin sensitivity points to S. epidermidis (a likely contaminant) rather than the uropathogen S. saprophyticus (novobiocin-resistant). The breakpoint and full procedure are on the novobiocin test page.

Detecting biofilm production. Because biofilm is central to this organism, laboratories sometimes test for it directly. Common approaches include growth on Congo red agar (biofilm-producing strains form black colonies) and tube or microplate adherence methods that stain the adherent film. These are mostly research and reference techniques rather than routine identification steps, but they illustrate the trait that defines S. epidermidis as a pathogen.

The core diagnostic problem is interpretation, not identification. Identifying S. epidermidis is straightforward. Deciding whether a given isolate is a real infection or a contaminant is the hard part, and it is the same judgment described for any skin commensal on a culture report: it depends on the number of positive cultures, whether a device is present, and the clinical picture. That reasoning is covered in normal flora of the skin.

Antimicrobial resistance

S. epidermidis is often more drug-resistant than S. aureus, which matters because these are hospital-associated, device-associated infections in vulnerable patients. Methicillin resistance is common among CoNS: like MRSA, methicillin-resistant S. epidermidis carries the mecA gene, which encodes an altered penicillin-binding protein (PBP2a) that beta-lactam drugs bind poorly, so the whole penicillin and cephalosporin class fails. Vancomycin is therefore often required for serious infections. For the mecA mechanism and its detection in detail, see MRSA: emergence, types, and detection.

Remember that this genetic resistance is separate from the biofilm-associated antibiotic tolerance described earlier. A strain can test fully susceptible in the lab and still resist cure in the patient, because the biofilm, not a resistance gene, is protecting it. Both problems can be present at once, which is part of why device infections are so difficult.

Where students get confused

• Coagulase-negative does not mean harmless. S. epidermidis is a weak pathogen on skin but a genuine and important one on devices. Dismissing every CoNS as a contaminant will miss real prosthetic and catheter infections.
• Susceptible in the lab does not mean curable in the patient. Biofilm makes S. epidermidis device infections tolerant to antibiotics that the isolate appears sensitive to on a susceptibility report. This is why device removal, not just a "correct" antibiotic, is often what actually cures the infection.
• Novobiocin runs the opposite way from S. saprophyticus. S. epidermidis is novobiocin-sensitive; S. saprophyticus is novobiocin-resistant. Mixing up the direction reverses the identification.
• Biofilm tolerance is not the same as methicillin resistance. One is a physical, reversible property of the biofilm state; the other is genetic (mecA). A strain can have either, both, or neither.

How to remember

The whole organism reduces to one idea: S. epidermidis is the plastic-loving staph. It is harmless on skin and dangerous on devices, and everything follows from that.

• Why it infects: it builds a biofilm on artificial surfaces (PIA, made by the ica genes). No device, usually no disease.
• Why it is hard to cure: the biofilm shelters it from antibiotics and the immune system, so the hardware often has to come out.
• How to place it among the staphylococci: coagulase-negative (not S. aureus), novobiocin-sensitive (not S. saprophyticus). Two tests put it in its box.

A one-line contrast for the three staphylococci: S. aureus is the aggressive one (coagulase-positive, toxins, abscesses); S. saprophyticus is the young women's UTI one (novobiocin-resistant); S. epidermidis is the device one (novobiocin-sensitive, biofilm).

Key exam facts

References

1. Otto M. Staphylococcus epidermidis: the "accidental" pathogen. Nat Rev Microbiol. 2009;7(8):555-567. https://doi.org/10.1038/nrmicro2182
2. Otto M. Staphylococcus epidermidis pathogenesis. Methods Mol Biol. 2014;1106:17-31. https://doi.org/10.1007/978-1-62703-736-5_2
3. Büttner H, Mack D, Rohde H. Structural basis of Staphylococcus epidermidis biofilm formation: mechanisms and molecular interactions. Front Cell Infect Microbiol. 2015;5:14. https://doi.org/10.3389/fcimb.2015.00014
4. Tille PM. Bailey and Scott's Diagnostic Microbiology. 15th ed. St. Louis: Elsevier; 2022.
5. Procop GW, Church DL, Hall GS, et al. Koneman's Color Atlas and Textbook of Diagnostic Microbiology. 7th ed. Philadelphia: Wolters Kluwer; 2017.